Graves Disease (Basedow's Disease)

DBCOND0050972Endocrine System DiseasesEye Disease

Graves Disease (Basedow's Disease) is the indication for 2 drugs in DrugBank. It is covered by 2 curated, structured indications.

Also known as
Basedow's disease · Graves' Disease · Graves´ Disease · Graves Disease · Grave's Disease
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0009624ICD-10E05.0SNOMED CT154655004MedDRA10004161UMLSC0018213

What you can answer from here — as of October 27, 2026

2Indicated drugsWith each drug's targets and mechanism
Listed above
2Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
89Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Contraindicated drugDrugs whose labels contraindicate them in this condition
Sign in
5Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Graves Disease (Basedow's Disease) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In